Literature DB >> 6139569

The therapeutic impact of temporal artery biopsy.

S Hall, S Persellin, J T Lie, P C O'Brien, L T Kurland, G G Hunder.   

Abstract

To evaluate the clinical usefulness of temporal artery biopsy in the diagnosis of giant-cell arteritis we followed up all 134 residents of Olmsted County, Minnesota, who had temporal artery biopsies between 1965 and 1980. Initial biopsies were positive for giant-cell arteritis in 46 cases and negative in 88. A history of jaw pain or claudication and the findings of a palpably abnormal temporal artery were significantly more common in the patients whose biopsy specimens showed giant-cell arteritis. Over a median follow-up period of 70 months (range 1-192) only 8 of the 88 biopsy-negative patients had clinical courses requiring long-term, high-dose corticosteroid therapy for giant-cell arteritis. In this population-based study temporal artery biopsy correctly predicted the subsequent need for corticosteroid therapy in 94% of cases: these findings indicate that biopsy should be done before patients are committed to long-term corticosteroid therapy.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6139569     DOI: 10.1016/s0140-6736(83)91269-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  38 in total

1.  Temporal artery biopsy: is there any value in examining biopsies at multiple levels?

Authors:  A Chakrabarty; A J Franks
Journal:  J Clin Pathol       Date:  2000-02       Impact factor: 3.411

2.  Temporal artery biopsy in the management of giant cell arteritis with neuro-ophthalmic complications.

Authors:  P Riordan-Eva; K Landau; J O'Day
Journal:  Br J Ophthalmol       Date:  2001-10       Impact factor: 4.638

3.  Color-coded sonography in suspected temporal arteritis-experiences after 83 cases.

Authors:  Matthias Reinhard; Dieter Schmidt; Andreas Hetzel
Journal:  Rheumatol Int       Date:  2003-11-05       Impact factor: 2.631

4.  Giant cell arteritis.

Authors:  L G Clearkin
Journal:  BMJ       Date:  1992-08-29

Review 5.  Giant cell arteritis and polymyalgia rheumatica: pathophysiology and management.

Authors:  Miguel A Gonzalez-Gay; Carlos Garcia-Porrua; Jose A Miranda-Filloy; Javier Martin
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

6.  Diagnostic value of high-resolution MR imaging in giant cell arteritis.

Authors:  T A Bley; M Uhl; J Carew; M Markl; D Schmidt; H-H Peter; M Langer; O Wieben
Journal:  AJNR Am J Neuroradiol       Date:  2007-09-20       Impact factor: 3.825

7.  Towards an optimal semiquantitative approach in giant cell arteritis: an (18)F-FDG PET/CT case-control study.

Authors:  Florent L Besson; Hubert de Boysson; Jean-Jacques Parienti; Gérard Bouvard; Boris Bienvenu; Denis Agostini
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-09-06       Impact factor: 9.236

8.  The influence of sectional interval on the reliability of temporal arterial biopsies in polymyalgia rheumatica.

Authors:  E Nordborg; C Nordborg
Journal:  Clin Rheumatol       Date:  1995-05       Impact factor: 2.980

9.  Diagnostic performance of ¹⁸F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a systematic review and meta-analysis.

Authors:  Florent L Besson; Jean-Jacques Parienti; Boris Bienvenu; John O Prior; Sylvie Costo; Gerard Bouvard; Denis Agostini
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-05-11       Impact factor: 9.236

10.  The contribution of ultrasound of the craniocervical arteries to the diagnosis of giant cell arteritis.

Authors:  Karl Pfadenhauer; Christoph Behr
Journal:  Clin Ophthalmol       Date:  2007-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.